View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Search Results for Cobalis Corp

Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20 Next >

Refine Search

Display Mode: Context | Summary

Cobalis Corp Gets Federal Court Approval to Launch Its Flagship Anti-Allergy Product PreHistin™

2009 JAN 26 ... Cobalis Corp. (OTC:CLSC), a pharmaceutical biotech Company specializing in the development of ...

Subject: Cobalis Corp.

Price: $3.00

Cobalis Corp, Maker of Revolutionary Allergy Relief Product PreHistin(R) "The World's FIRST Prehistamine" Confirms Filing of Five Count Lawsuit Against Yorkville Advisors/YA Gl

2009 DEC 1 ... Cobalis Corporation (Pink Sheets: CLSC) confirms filing Five Count Adversarial Complaint on ...

Subject: Cobalis Corporation

Price: $3.00

Cobalis Corporation and International Shipping and Marketing LLC Announce Signed Letter of Intent for Distribution and Marketing of Flagship Anti-Allergy Product PreHistin®

2009 JUN 15 ... and monetize their significant international and domestic patents for PreHistin®. ABOUT COBALIS CORP—PREHISTIN® Headquartered in Irvine, California,...

Subject: Cobalis Corporation

Price: $3.00

Cobalis Corporation is Awarded Two New International Patents in Canada and Mexico for Its Revolutionary Anti-Allergy Relief Product PreHistin®

2009 JUN 22 ... by DSHEA (Dietary Supplement Health and Education Act) regulation attorneys." ABOUT COBALIS CORP—PREHISTIN® "The World's First Pre-Histamine" Headquartered in Irvine, California, ...

Subject: Cobalis Corporation

Price: $3.00

Allergy Patients Treated with PreHistin Had Rise in Ragweed IgE Antibodies Blunted During Pollen Season

2007 SEP 10 ... Cobalis Corp. (OTCBB:CLSC), a pharmaceutical company specializing in anti-allergy medications, ...

Subject: Allergies

Price: $3.00

Cobalis Announces Delay in Reporting of Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis

2007 JUN 18 ... Cobalis Corp. (OTCBB:CLSC), a pharmaceutical development company specializing in anti-allergy ...

Subject: Clinical Trial Research

Price: $3.00

Cobalis Announces Second Closing in $3.85 Million Funding

2007 MAR 5 ... Cobalis Corp. (OTC BB: CLSC) a pharmaceutical development company specializing in anti-allergy ...

Subject: Clinical Trials

Price: $3.00

Cobalis Appoints Three Pharmaceutical Industry Executives to Board

2007 MAR 5 ... Cobalis Corp. (OTC BB: CLSC), a pharmaceutical development company specializing in anti-allergy ...

Subject: Biotech Business

Price: $3.00

Cobalis completes enrollment in twin Phase III clinical trials for PreHistin

2006 OCT 2 ... Cobalis Corp. (CLSC), a pharmaceutical development company specializing in anti-allergy medications, ...

Subject: Respiratory Medicine

Price: $3.00

Cobalis Completes Funding; Expects Top-Line Phase III Trial Results for PreHistin in April 2007

2007 APR 2 ... Cobalis Corp. (OTC BB: CLSC) a pharmaceutical development company specializing in anti-allergy ...

Subject: Clinical Trial Research

Price: $3.00

Cobalis completes patient dosing in Phase III clinical trials for OTC anti-allergy product

2006 NOV 6 ... Cobalis Corp. (CLSC) a pharmaceutical development company specializing in anti-allergy medications, ...

Subject: Allergy & Immunology

Price: $3.00

Cobalis Corp. provides an activity update

2007 OCT 8 ... Cobalis Corp. provides an activity update. This trend article is an immediate alert ...

Subject: Cobalis Corp.

Price: $3.00

Cobalis Locks Database for Pivotal Twin Phase III Trials of PreHistin in Seasonal Allergic Rhinitis

2007 APR 9 ... Cobalis Corp. (OTC BB: CLSC), a pharmaceutical development company specializing in anti-allergy ...

Subject: Allergies

Price: $3.00

Cobalis provides update on clinical program for PreHistin

2006 JUL 10 ... Cobalis Corp. (CLSC), a pharmaceutical development company focused on the treatment of allergy and ...

Subject: Allergy & Immunology

Price: $3.00

Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis

2007 JUL 16 ... Cobalis Corp. (OTCBB:CLSC), a pharmaceutical development company specializing in anti-allergy ...

Subject: Allergies

Price: $3.00

Cobalis' E.U. patent for PreHistin becomes effective

2006 JUL 17 ... Cobalis Corp. (CLSC) announced that its Patent No. 1128835, titled "Cyanocobalamin Treatment in ...

Subject: Patents

Price: $3.00

New activities and developments reported by Cobalis

2006 DEC 19 ... to identify the most recent news developments at Cobalis. Report 1: Cobalis Corp. (CLSC) a pharmaceutical development company specializing in anti-allergy medications, ...

Subject: Cobalis

Price: $3.00

Officials from Cobalis Corp. provide details of new developments

2007 JUL 31 ... Officials from Cobalis Corp. provide details of new developments. This trend article is an immediate ...

Subject: Cobalis Corp.

Price: $3.00

Recent developments from Cobalis summarized

2007 JAN 15 ... to identify the most recent news developments at Cobalis. Report 1: Cobalis Corp. (CLSC) a pharmaceutical development company specializing in anti-allergy medications, ...

Subject: Cobalis

Price: $3.00

Researchers from Sweden, over-the-counter anti-allergy treatment option for allergy sufferers that goes beyond currently available remedies and a clinical professor at the University of Colorado and noted expert in th

2007 AUG 29 ... Dept. of Respiratory Medicine and Allergology, Lund, Sweden. Study 2: Cobalis Corp. (OTC BB: CLSC), a pharmaceutical development company specializing in anti-allergy ...

Subject: Allergies

Price: $3.00

Results 1 - 20 Next >


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx